MMJ International Holdings, an FDA IND-stage pharmaceutical cannabinoid developer, is a plaintiff in landmark litigation ...
New data demonstrate that transgenic American chestnuts produce significantly smaller blight cankers than their wild-type counterparts MCGRAW, NY / ACCESS Newswire / April 25, 2026 / Today, SilvaBio, ...
Can CMS put cannabinoids into Medicare for reimbursement without FDA approval, without safety analysis, and without public rule making?" stated Duane Boise, CEO MMJ International Holdings. WASHINGTON, ...
Paying Patients to Access the Nation’s #1 Prescribed Oral Blood ThinnerPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #Eliquis--The Bristol Myers Squibb-Pfizer (BMS NYSE: BMY) — (Pfizer NYSE: PFE) Alliance ...
Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory ...
MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop
Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged ...
UPPSALA, SE / ACCESS Newswire / April 24, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) announces today that the company's annual and sustainability report for 2025 is published and ...
PharmaNest, a leader in high-resolution single-fiber digital pathology and AI, will present five communications at Digestive Disease Week (DDW) 2026, showcasing its advanced technologies for the study ...
Ondine Biomedical Inc. (AIM: OBI), a global leader in light-activated antimicrobial therapies, announces that the University of Ottawa Heart Institute (“UOHI”), Canada’s largest and foremost academic ...
BOULDER, CO / ACCESS Newswire / April 24, 2026 / Sonoma Pharmaceuticals, Inc. (the "Company" or "Sonoma Pharmaceuticals") ...
Separate poster will feature long-term safety and tolerability data from STARS clinical trial program of apraglutide in adults with SBS who are dependent on parenteral support (PS) –– Linaclotide data ...
GOTHENBURG, SE / ACCESS Newswire / April 24, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results